BSEBoard MeetingResults26 Sept 2026
Samrat Pharmachem Ltd-$
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Samrat Pharmachem Limited - has informed BSE Ltd that the meeting of Board of Directors of the Company is scheduled on 14/11/2026, to consider and approve the Un-audited financial results for the quarter ended September 30, 2026.
Samrat Pharmachem Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Un-audited financial results for the quarter ended September 30, 2026.
BSEInsider Trading / SAST26 Sept 2026
Samrat Pharmachem Ltd-$
Trading window shall remain closed from 01-10-2026 till 48 hours after declaration of UFR for the quarter ended September 30, 2026.
Samrat Pharmachem Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations.
BSECompany UpdateAuditor Change24 Sept 2026
Samrat Pharmachem Ltd-$
The share holders of the company at the 34th AGM held on 23-09-2026, have approved the appointment of M/s. Divyesh J Shah & Associates, Chartered Accountants as Statutory Auditors of the Company in place of the retiring auditors M/s. Shah & Savla LLP to hold office for a term of five years from conclusion of 34th AGM till the conclusion of 39th AGM to be held in 2031. Appointed with effect from 23-09-2026.
Samrat Pharmachem Ltd has appointed M/s. Divyesh J Shah & Associates as its new statutory auditors, replacing M/s. Shah & Savla LLP, with effect from the conclusion of the 34th AGM till the conclusion of the 39th AGM in 2031.
BSEAGM/EGMResults24 Sept 2026
Samrat Pharmachem Ltd-$
Scrutinizer''s Report & Voting Results for 34th AGM
Samrat Pharmachem Ltd's 34th AGM saw all resolutions approved by shareholders with requisite majority, as per the Scrutinizer's Report and Voting Results.
BSEAGM/EGM23 Sept 2026
Samrat Pharmachem Ltd-$
The Company''s 34th AGM was held on 23rd September 2026 and the business mentioned in the prior notice was transacted.
Samrat Pharmachem Ltd held its 34th Annual General Meeting on September 23, 2026, through video conferencing. The meeting was attended by 39 members and the company's directors, who discussed the company's performance and future plans.
BSECompany Update2 Sept 2026
Samrat Pharmachem Ltd-$
Notice of 34th AGM - Newspaper Publication
Samrat Pharmachem Ltd has announced the notice of its 34th Annual General Meeting (AGM) to be held on September 23, 2026, through video conference. The company has also provided the facility for remote e-voting from September 20 to 22, 2026.
BSECorp. Action27 Aug 2026
Samrat Pharmachem Ltd-$
The Register of Members and Share Transfer books will remain closed from September 20,2026 To September 22, 2026 (both days inclusive)
Samrat Pharmachem Ltd will hold its 34th Annual General Meeting (AGM) on September 23, 2026, through video conferencing. The register of members and share transfer books will be closed from September 20 to 22, 2026, for the purpose of the AGM.
BSEAGM/EGM27 Aug 2026
Samrat Pharmachem Ltd-$
34th Annual General Meeting of the company will be held on Wednesday, September 23, 2026 at 1:00 PM (IST) through Video Conferencing (VC) / Other Audio Video Means (OAVM)
Samrat Pharmachem Ltd will hold its 34th Annual General Meeting (AGM) on September 23, 2026, through video conferencing. The register of members and share transfer books will be closed from September 20 to 22, 2026. Members can cast their votes through remote e-voting from September 20 to 22, 2026.
BSEOthersResults27 Aug 2026
Samrat Pharmachem Ltd-$
34th Annual Report for the Financial Year 2025-26
Samrat Pharmachem Ltd has announced its 34th Annual Report for the financial year 2025-26, which includes details of its iodine extraction process, two sustainable paths in Chile and Japan, and the company's board of directors and general information.
BSECompany UpdateResults19 Aug 2026
Samrat Pharmachem Ltd-$
Newspaper Publication of extract of Standalone Unaudited Financial Results for the quarter ended June 30, 2026.
Samrat Pharmachem Ltd has published the extract of its standalone unaudited financial results for the quarter ended June 30, 2026, in newspapers as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
BSEBoard MeetingResults14 Aug 2026
Samrat Pharmachem Ltd-$
The Board considered and adopted the unaudited financial results for the quarter ended June 30, 2026
Samrat Pharmachem Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 87.60 lakhs, compared to a loss of Rs. 203.63 lakhs in the same quarter last year.